150
Participants
Start Date
November 29, 2018
Primary Completion Date
May 31, 2021
Study Completion Date
May 31, 2021
Neu2000KWL High-dose group
1st infusion of 1500mg in patients within 4 hours following sudden cardiac arrest onset followed by 5 consecutive infusions of 750 mg at intervals of 12 hours(Total drug dosage is 5250mg.)
Neu2000KWL Low-dose group
1st infusion of 750mg in patients within 4 hours following sudden cardiac arrest onset followed by 5 consecutive infusions of 500 mg at intervals of 12 hours (Total drug dosage is 3250mg.)
Placebo
1st infusion of the same volume of saline in patients within 4 hours following sudden cardiac arrest onset followed by 5 consecutive infusions of the same volume of saline at intervals of 12 hours
Soonchunhyang University Bucheon Hospital, Bucheon-si
Kyungpook National University Hospital, Daegu
Pusan National University Hospital, Busan
Chonnam National University Hospital, Gwangju
Gangnam Severance Hospital, Seoul
Samsung Medical Center, Seoul
Lead Sponsor
Samsung Medical Center
OTHER
Chonnam National University Hospital
OTHER
Gangnam Severance Hospital
OTHER
Kyungpook National University Hospital
OTHER
Pusan National University Hospital
OTHER
Soonchunhyang University Hospital
OTHER
GNT Pharma
INDUSTRY